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BLOCKING  OF  IN  VITRO  AND  IN  VIVO 
SUSCEPTIBILITY TO  MOUSE  HEPATITIS VIRUS 
BY W.  Y.  WEISER ANY F.  B.  BANG 
(From the Department of Pathobiology, The Johns Hopkins  University, School of Hygiene and 
Public Health, Baltimore,  Maryland 21205) 
During the last  15 yr,  an increasing  number  of experiments  has shown that 
genetic  susceptibility  to  mouse  hepatitis  virus  (MHV)  and  its  phenotypic 
alteration  induced  by  drugs  and  immune  responses  respond  in  a  parallel 
fashion in the intact  mouse and in cultures  of macrophages.  Thus the in vitro 
macrophage  mirrors  the  susceptibility  of  the  host.  In  a  recent  series  of 
experiments  it  was  shown  that  lymphokines  given  to  resistant  macrophages 
convert  them  to  susceptibility  (1).  Thus  it  may be relevant  to concentrate  on 
the  numerous  interactions  of macrophages  and  lymphocytes  in  the  study  of 
susceptibility. 
No significant  attempts  to change susceptible  cells  into resistant  ones  have 
been  reported.  When  investigating  whether  concanavalin  A  (Con  A)  might 
stimulate  lymphocytes  to  change  the  susceptibility  of the  macrophages,  we 
found that  genetically  susceptible  macrophages  were  converted  into  resistant 
cells by Con A  administration,  and that a  significant percentage of susceptible 
mice were saved from death by Con A. 
Materials  and  Methods 
Mice.  4- to 6-wk-old  inbred Princeton (PRI)  mice were used.  This strain of mice has been 
maintained in our laboratory through brother-sister mating since 1955. 
Virus.  The MHV-2 strain of mouse hepatitis  virus was originally obtained from Dr.  John 
Nelson of the  Rockefeller Institute  in  1952 and  has  since  been  passed  in  our laboratory by 
intraperitoneal inoculation and I mo old PRI mice. This is the MHV-PRI virus and here it will be 
referred to simply as MHV. Methods of preparing stock virus have been previously described (1). 
Macrophage Cultures.  Methods of harvesting and preparing  cultures of mouse peritoneal 
macrophages have been previously described in detail (2). 
Con A.  Bacto-Con A  50 mg in  1 M NaC1 was obtained from Difco Laboratories,  Detroit, 
Mich. It was kept at 4°C and rehydrated with distilled water. 
Preparation of Supernatant  Fluid from Con A-Treated Spleen  Cell Cultures.  1 mg/mouse of 
Con A was injected intraperitoneally in PRI mice.  Spleens were removed 3 days after injection 
and passed through a  60-mesh  stainless  steel  wire cloth (Small Parts,  Inc., Miami,  Fla.).  10  ~ 
cells/ml were suspended in a  medium consisting of 2 ~g/ml of Con A, 80% RPMI-1640 (Grand 
Island Biological  Co., Grand Island, N. Y.), 20% Changes medium (2), and 100 ~g/mg per ml of 
penicillin and streptomycin, and cultivated in 2  ×  15-cm centrifuge tubes in a 37°C incubator 
supplemented  with  5%  CO2. After  3  days  incubation,  supernatant  fluid  was  obtained  by 
centrifuging the cell suspension at 1,000 rpm for 30 min. 
Results 
Effect of Con A  on Survival  among  Genetically  Susceptible  PRI  Mice after 
MHV  Infection.  Each experimental  mouse  was  injected  i.p.  with  1.0  rag/0.1 
ml of Con A. 3 days later, 3 log10 mean lethal dose (LDso) of MHV was inoculated 
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FIG.  1.  Cumulative mortality of normal and Con A-treated PRI mice infected with MHV. 
Data were pooled from several experiments. Sample size: 50 mice (circles); 30 mice (squares). 
i.p.  into both experimental  and control mice. Lethargy and ruffled fur became 
noticeable 36 h after MHV infection and the disease rapidly progressed to death 
in the untreated mice, while the onset of these symptoms was delayed among 
Con A-treated mice.  Mortality among  control mice commenced on day 2 and 
reached 100% by day 3. Some of the Con A-treated mice began to die on day 5, 
mortality  increased  on days 6 and  7,  and  ceased on day 8.  The  survival rate 
was  more  than  60%  (Fig.  1).  However,  when  phytohemagglutinin  (Grand 
Island Biological Co.), another T-cell mitogen at a dose between 0.1 -  1.5 mg, 
or thioglycollate (Difco Laboratories) which increases the number of peritoneal 
macrophages, was used instead of Con A, no significant prolongation of survival 
time nor protection from death was obtained. Intraperitoneal  injections of Con 
A  and MHV simultaneously at adjacent sites, or injection of a  mixture of Con 
A and MHV failed to prevent death of PRI mice. 
At autopsy, the liver of every untreated moribund mouse was very pale and 
full of necrotic foci, whereas livers from 10 Con A-treated mice sacrificed at the 
same time showed only a few necrotic foci. The microscopic difference between 
Con A-treated and untreated mice was striking  (Fig.  2). In the Con A-treated 
mice, MHV infection was accompanied by infiltration of mononuclear cells and 
polymorphonuclear cells.  They surrounded the  small necrotic foci, suggesting 
that  the  destructive  effect of the  virus  to  the  liver  parenchymal  cells  was 
arrested by inflammatory cells, whereas in the untreated controls the inflam- 
matory response was absent or minimal, the necrotic foci were large, and little 
normal tissue remained. 
Susceptibility  of Peritoneal  Macrophages  from  Con  A-Treated  Mice  to 
MHV.  Since genetic susceptibility to MHV resides largely in the macrophages 
of susceptible PRI mice (3), and cultured macrophages derived from peritoneal 
washings also reflect the genetic MHV trait of the host (2), the susceptibility of 
cells from the  peritoneum  of Con A-treated mice was determined.  Peritoneal 
washings from thioglycollate-stimulated mice were used as controls. They were 
harvested  3  days  after  i.p.  injection  of thioglycollate.  Experimental  cultures 
were derived from peritoneal  washings of day 3 Con A-treated mice  (1.0 mg/ 
mouse). After attachment,  100 tissue culture mean infectious dose (TCIDso)/0.1  ~ 
ml of MHV was  inoculated  into each tube.  All thioglycollate-stimulated  PRI 
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FIG. 2.  H  &  E  section of liver. (a) MHV-infected  control liver, 3 days postinfection: 
absence of  inflammatory response and large necrotic  loci. x 250.  (b) Liver from Con A- 
treated  mouse, 3  days  postinfection:  prominent infiltration  of  inflammatory cells,  x 250. 
phages from Con A-treated mice were not uniformly susceptible to the virus 
(Fig.  3). In  other words, there was phenotypic variation among the genetically 
susceptible cells. 
Effect of Supernatant Fluid Derived from  Con A-Treated Spleen  Cells  on 
Syngeneic  MHV-Susceptible  Macrophages.  1/lO ml of supernatant fluid de- 
rived from Con A-treated spleen cells was added to each normal macrophage 
culture. After overnight incubation, 2 log~oTCIDso U of MHV were inoculated. 
Fig. 4 shows that macrophages incubated with supernatant fluid derived from 
Con A-activated spleen cells were protected against the cytopathic effect of the 
virus during 5 days of observation, while in the untreated controls, cultured 
macrophages were all destroyed 2 days after MHV infection. Supernatant fluid 
from normal PRI spleen cells or medium containing 2 ~tg/ml of Con A alone 
conferred no protection against MHV when incubated with syngeneic macro- 
phages before infection. Therefore, supernatant fluid from Con A-treated spleen 
cells contained a  factor or factors which made genetically susceptible macro- 
phages resistant to MHV. This factor(s) was found to be acid (pH 2)-labile,  but 
was effective after freezing at -70°C or heating at 56°C for 30 min. 
Discussion 
It is well known that lymphokines can be produced via a variety of stimuli. 
In previous work we demonstrated a susceptibility factor obtained from super- 
natant  fluid  of allogeneic mixed  lymphocyte cultures which phenotypically 
altered the resistance of genetically resistant C3H macrophages and rendered 
them susceptible to MHV (1). In searching for other susceptibility factors, Con 
A  was used as  a  nonspecific polyclonal stimulator.  However,  it  produced a 
factor(s) which conferred resistance on genetically susceptible cells and mice. 
The first of the present experiments (Fig.  1) showed that i.p.  injection of Con 
A  at  1.0  mg/mouse prolonged the  median survival  time  and  increased the 
chance for survival from 0 to greater than 60% among genetically susceptible 1470  WEISER  AND  BANG  BRIEF  DEFINITIVE  REPORT 
Fro. 3.  Macrophages from Con A-treated PRI mice, infected  with i00  TCID~ of  MHV,  3 
days postinfection.  Though many cells  have detached from culture  tube,  the majority of 
cells  remains intact,  x 150. 
PRI mice.  Infected controls developed a  fulminating  necrosis of the liver with 
little or no inflammation,  while Con A-treated mice developed small necrotic 
foci  surrounded  by  a  wide  zone  of inflammatory  cells  (Fig.  2).  Since  mice 
treated  with  Con  A  alone  showed no  cellular  infiltration,  it  is  possible that 
after infection with MHV, Con A activated the macrophages and lymphocytes 
so that  they secreted a  variety of biologically active mediators which brought 
about the  inflammatory  response  and  slowed down virus multiplication.  The 
fact  that  adding  virus  to  the  Con  A  solution  or  injecting  Con  A  and  virus 
concomitantly at adjacent sites produced no protective effect also supports the 
idea  that  the  action  of Con  A  was via mediators  and  was not due  to direct 
inactivation  of the  virus.  Moreover,  survivors  were  found  to  be  immune  to 
MHV upon challenge,  which indicates that there was extensive viral multipli- 
cation in the Con A-treated mice. The importance of local (peritoneal) changes 
in the macrophage population, which may be bypassed by intravenous inocula- 
tion of the virus,  is under study. 
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FIG.  4.  PRI  macrophages.  (a)  Normal  PRI  macrophages  infected  with  100  TCIDso  of 
MHV, 2 days after infection:  severe destruction and loss of cells from culture tube.  ×  150. 
(b) Normal PRI macrophages with 0.1 ml of supernatant fluid from Con A-activated spleen 
cells  added  before  addition  of 100  TCIDso  of MHV,  5  days  al~er  infection:  no  apparent 
destruction,  x  150. 
susceptible macrophages in the presence of 0.1  ml of supernatant fluid from 
cultures of spleen cells which had been activated in vivo by Con A for 72 h. 
This prevented death of the cells  (Fig.  4b).  Fluid from control cultures, or 
culture  medium  containing  Con  A  alone,  did  not  protect  the  susceptible 
macroophages  (Fig.  4a).  Because  lectins  can  stimulate  the  production  of 
interferon by lymphocytes (3,  4),  it was necessary to test whether the factor 
present in the supernatant fluid was a type of interferon. We have not yet been 
able to rule out the possibility that type II interferon (5) is responsible. It is 
known that Con A exerts multiple effects on lymphocytes, depending on the 
experimental conditions. Pierce et al.  and Tadakuma and Pierce studied the 
production  of a  soluble  immune response  suppressor  (SIRS)  stimulated  in 
lymphocytes by Con A  and showed that  SIRS  mediated its  suppression via 
macrophages (6, 7). However, our system produced results which were opposite 
to an expected depression in immunity. Con A stimulated immunity to MHV, 
presumably suggesting a very different mechanism. 1472  WEISER  AND  BANG  BRIEF  DEFINITIVE  REPORT 
Summary 
By  pretreatment  with  concanavalin  A  (Con A)  both  in  vivo  and  in  vitro 
genetically  susceptible  mice  and their  cultured macrophages  have been con- 
verted  to  animals  and  cells  which  are  phenotypically  resistant  to  mouse 
hepatitus virus (MHV).  Con A  at 1.0 mg/mouse decreased the mortality from 
100%  to  less  than  40%  by  inducing  a  prominent  inflammatory  response, 
increasing  the  number  of  macrophages  in  the  virus  inoculation  site,  and 
producing a population of macrophages not uniformly susceptible to the virus. 
In  addition,  mediators  derived  from  Con  A-treated  spleen  cells  conferred 
resistance  to  normally  susceptible  syngeneic  macrophages  to  100  TCIDso of 
MHV. 
Received for publication 31 May 1977. 
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